百万退伍军人计划中传统风险因素与多基因风险评分的心血管病风险评估
该研究基于百万退伍军人计划(MVP)中79 151名无动脉粥样硬化性心血管病(ASCVD)且未用他汀的成年人,评估冠状动脉病(CAD)和缺血性卒中的全基因组多基因风险评分(PRS)在传统临床风险因素基础上是否改善ASCVD风险估计。结果显示PRS在多种族中年人群中与ASCVD事件显著相关,但加入传统风险模型后对区分度的改善有限,女性和年轻人群改善幅度较大。
要点
- CAD PRS与非西班牙裔黑人、西班牙裔和非西班牙裔白人的 incident MI 显著相关。
- 联合CAD+卒中PRS与全部祖先背景的复合ASCVD事件相关,非西班牙裔白人效应更强。
- 将PRS加入传统风险模型对中间风险组的净重分类改善有限,女性改善幅度大于男性。
核心结论
- 主要基于欧洲样本衍生的PRS在多种族中年及老年MVP队列中与ASCVD显著相关。
- 在传统风险因素基础上加入PRS对区分度指标仅有适度改善,女性和年轻年龄组改善幅度更大。
研究设计与样本
- 研究为回顾性定义纵向队列中 incident 事件的预后分析,数据收集自2011年1月1日至2018年12月31日。
- 纳入百万退伍军人计划(MVP)中基线无ASCVD且未使用他汀的成年人,共79 151名参与者。
- 参与者平均(SD)年龄57.8(13.7)岁,男性68 503名(86.5%),中位(5th-95th百分位)随访4.3(0.7-6.9)年。
主要发现
- 2011至2018年观察到3186例心肌梗死(4.0%)、1933例缺血性卒中(2.4%)、867例ASCVD死亡(1.1%)和5485例复合ASCVD事件(6.9%)。
- CAD PRS与 incident MI 的关联:非西班牙裔黑人HR 1.10(95% CI 1.02-1.19),西班牙裔HR 1.26(95% CI 1.09-1.46),非西班牙裔白人HR 1.23(95% CI 1.18-1.29)。
- 卒中PRS与 incident stroke 的关联仅非西班牙裔白人显著:HR 1.15(95% CI 1.08-1.21)。
- 联合CAD+卒中PRS与ASCVD死亡的关联:非西班牙裔黑人HR 1.19(95% CI 1.03-1.17),西班牙裔HR 1.11(95% CI 1.03-1.21)。
- 联合PRS与复合ASCVD的关联:非西班牙裔白人HR 1.20(95% CI 1.16-1.24),非西班牙裔黑人HR 1.11(95% CI 1.05-1.17),西班牙裔HR 1.12(95% CI 1.00-1.25)。
关键数值与推荐
- 将PRS加入传统风险模型后,复合CVD中间风险组(5年风险>3.75%)的净重分类改善:男性0.38%(95% CI 0.07%-0.68%)。
- 女性净重分类改善6.79%(95% CI 3.01%-10.58%)。
- 年龄>55岁净重分类改善0.25%(95% CI 0.03%-0.47%),年龄40-55岁为1.61%(95% CI -0.07%至3.30%)。
临床怎么用
- 在多种族中年人群中,PRS可提供与传统风险因素独立相关的ASCVD风险信息。
- PRS加入传统风险模型对中间风险组的重分类改善有限,临床决策时需结合女性和年轻人群可能获益更大的特点。
局限性
- PRS主要基于欧洲血统样本衍生,在非欧洲祖先人群中的效应估计和校准可能受限。
- 研究为观察性队列分析,PRS的临床效用需在前瞻性干预研究中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Primary prevention of atherosclerotic cardiovascular disease (ASCVD) relies on risk stratification. Genome-wide polygenic risk scores (PRSs) are proposed to improve ASCVD risk estimation. OBJECTIVE: To determine whether genome-wide PRSs for coronary artery disease (CAD) and acute ischemic stroke improve ASCVD risk estimation with traditional clinical risk factors in an ancestrally diverse midlife population. DESIGN, SETTING, AND PARTICIPANTS: This was a prognostic analysis of incident events in a retrospectively defined longitudinal cohort conducted from January 1, 2011, to December 31, 2018. Included in the study were adults free of ASCVD and statin naive at baseline from the Million Veteran Program (MVP), a mega biobank with genetic, survey, and electronic health record data from a large US health care system. Data were analyzed from March 15, 2021, to January 5, 2023. EXPOSURES: PRSs for CAD and ischemic stroke derived from cohorts of largely European descent and risk factors, including age, sex, systolic blood pressure, total cholesterol, high-density lipoprotein (HDL) cholesterol, smoking, and diabetes status. MAIN OUTCOMES AND MEASURES: Incident nonfatal myocardial infarction (MI), ischemic stroke, ASCVD death, and composite ASCVD events. RESULTS: A total of 79 151 participants (mean [SD] age, 57.8 [13.7] years; 68 503 male [86.5%]) were included in the study. The cohort included participants from the following harmonized genetic ancestry and race and ethnicity categories: 18 505 non-Hispanic Black (23.4%), 6785 Hispanic (8.6%), and 53 861 non-Hispanic White (68.0%) with a median (5th-95th percentile) follow-up of 4.3 (0.7-6.9) years. From 2011 to 2018, 3186 MIs (4.0%), 1933 ischemic strokes (2.4%), 867 ASCVD deaths (1.1%), and 5485 composite ASCVD events (6.9%) were observed. CAD PRS was associated with incident MI in non-Hispanic Black (hazard ratio [HR], 1.10; 95% CI, 1.02-1.19), Hispanic (HR, 1.26; 95% CI, 1.09-1.46), and non-Hispanic White (HR, 1.23; 95% CI, 1.18-1.29) participants. Stroke PRS was associated with incident stroke in non-Hispanic White participants (HR, 1.15; 95% CI, 1.08-1.21). A combined CAD plus stroke PRS was associated with ASCVD deaths among non-Hispanic Black (HR, 1.19; 95% CI, 1.03-1.17) and non-Hispanic (HR, 1.11; 95% CI, 1.03-1.21) participants. The combined PRS was also associated with composite ASCVD across all ancestry groups but greater among non-Hispanic White (HR, 1.20; 95% CI, 1.16-1.24) than non-Hispanic Black (HR, 1.11; 95% CI, 1.05-1.17) and Hispanic (HR, 1.12; 95% CI, 1.00-1.25) participants. Net reclassification improvement from adding PRS to a traditional risk model was modest for the intermediate risk group for composite CVD among men (5-year risk >3.75%, 0.38%; 95% CI, 0.07%-0.68%), among women, (6.79%; 95% CI, 3.01%-10.58%), for age older than 55 years (0.25%; 95% CI, 0.03%-0.47%), and for ages 40 to 55 years (1.61%; 95% CI, -0.07% to 3.30%). CONCLUSIONS AND RELEVANCE: Study results suggest that PRSs derived predominantly in European samples were statistically significantly associated with ASCVD in the multiancestry midlife and older-age MVP cohort. Overall, modest improvement in discrimination metrics were observed with addition of PRSs to traditional risk factors with greater magnitude in women and younger age groups.
引用
- Vassy JL, Posner DC, Ho YL, et al. Cardiovascular Disease Risk Assessment Using Traditional Risk Factors and Polygenic Risk Scores in the Million Veteran Program. JAMA Cardiol. 2023. PMID: 37133828. doi:10.1001/jamacardio.2023.0857
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。